VAERS reports by lot

Pfizer COVID-19 lot LM2216: VAERS reports

93 VAERS reports list lot LM2216 as a Pfizer COVID-19 vaccine, received between 2024-08-27 and 2024-12-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
93
Reports
11%
Marked serious
1
With a death outcome
5
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5217%
Injection-site / Local reaction4415%
Neurological4314%
Dermatological (non-injection-site)3813%
Musculoskeletal3010%
Cardiac / Cardiovascular2910%
Gastrointestinal279%
Allergic / Anaphylactic155%
Respiratory155%
Thrombotic / Hematological52%
Psychiatric / Neuropsychiatric41%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania8
Florida6
Texas6
Georgia6
New York6
North Carolina5
Missouri5
Massachusetts4
California4
Colorado4
Ohio4
Indiana3

Reports by month received

2024-084
2024-0952
2024-1022
2024-118
2024-127

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.